share_log

Illumina | SC 13G: Statement of acquisition of beneficial ownership by individuals-Illumina, Inc.(14.5%)

Illumina | SC 13G: Statement of acquisition of beneficial ownership by individuals-Illumina, Inc.(14.5%)

Illumina | SC 13G：超過5%持股股東披露文件-Illumina, Inc.(14.5%)
美股SEC公告 ·  08/14 15:53

Moomoo AI 已提取核心訊息

Illumina, Inc., a biotechnology company based in Delaware, has filed a Schedule 13G with the U.S. Securities and Exchange Commission on August 14, 2024, indicating a significant ownership stake in GRAIL, Inc. following a corporate spin-off. On June 24, 2024, Illumina completed the distribution of approximately 85.5% of GRAIL's common stock to Illumina's shareholders. Post spin-off, Illumina retained direct ownership of 4,502,126 shares, representing 14.5% of GRAIL's outstanding common stock. The filing also notes that Illumina has granted GRAIL a proxy to vote its shares in alignment with the majority of GRAIL's stockholders. The reported ownership percentage is based on 31,049,148 shares of GRAIL's common stock outstanding as of August 11, 2024.
Illumina, Inc., a biotechnology company based in Delaware, has filed a Schedule 13G with the U.S. Securities and Exchange Commission on August 14, 2024, indicating a significant ownership stake in GRAIL, Inc. following a corporate spin-off. On June 24, 2024, Illumina completed the distribution of approximately 85.5% of GRAIL's common stock to Illumina's shareholders. Post spin-off, Illumina retained direct ownership of 4,502,126 shares, representing 14.5% of GRAIL's outstanding common stock. The filing also notes that Illumina has granted GRAIL a proxy to vote its shares in alignment with the majority of GRAIL's stockholders. The reported ownership percentage is based on 31,049,148 shares of GRAIL's common stock outstanding as of August 11, 2024.
生物技術公司 illumina，總部位於特拉華州，於2024年8月14日向美國證券交易委員會提交了13G表格，表示在 GRAIL 公司的一次企業分拆後持有重要的所有權。2024年6月24日，illumina 完成了向其股東分配 GRAIL 普通股約85.5%的股份。分拆後，illumina 直接持有4502126股 GRAIL 普通股，佔 GRAIL 出色普通股的14.5％。文件還指出，illumina 向 GRAIL 授權代理投票，以與 GRAIL 大多數股東的利益一致。所報告的所有權百分比基於2024年8月11日 GRAIL 普通股的31049148股。
生物技術公司 illumina，總部位於特拉華州，於2024年8月14日向美國證券交易委員會提交了13G表格，表示在 GRAIL 公司的一次企業分拆後持有重要的所有權。2024年6月24日，illumina 完成了向其股東分配 GRAIL 普通股約85.5%的股份。分拆後，illumina 直接持有4502126股 GRAIL 普通股，佔 GRAIL 出色普通股的14.5％。文件還指出，illumina 向 GRAIL 授權代理投票，以與 GRAIL 大多數股東的利益一致。所報告的所有權百分比基於2024年8月11日 GRAIL 普通股的31049148股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間